Results 171 to 180 of about 161,432 (294)

Voice and Speech in Atypical Parkinsonian Disorders

open access: yesMovement Disorders Clinical Practice, EarlyView.
Background Motor speech disorders are early, common, and functionally limiting features of atypical parkinsonian disorders (APDs) such as progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy (MSA). These impairments are underrecognized and undertreated in neurology clinics.
Federico Rodriguez‐Porcel   +48 more
wiley   +1 more source

Why wait for referral: Gastroenterologist use of micro interventions to address patient cognitive distortions

open access: yes
Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Christina Low Kapalu   +3 more
wiley   +1 more source

TopoMAS: Large Language Model Driven Topological Materials Multi‐Agent System

open access: yesMaterials Genome Engineering Advances, EarlyView.
TopoMAS is an interactive multi‐agent framework that revolutionizes topological materials discovery through human–AI collaborative intelligence. The system integrates natural language processing, knowledge retrieval from literature and databases, crystal structure generation, and automated first‐principles calculations within a unified workflow.
Baohua Zhang   +5 more
wiley   +1 more source

Washed Microbiota Transplantation Using Ileocolic Transendoscopic Enteral Tubing Versus Basic Treatments for Intestinal Inflammatory Obstruction in Crohn's Disease: A Multicenter Concurrent Controlled Trial

open access: yesMicrobiota Medicine Research, EarlyView.
Washed microbiota transplantation using ileocolic transendoscopic enteral tubing was identified as a viable, effective and safe bridge treatment for intestinal inflammatory obstruction in Crohn's disease, demonstrating significantly higher 28‐day improvement rates compared to basic treatment.
You Yu   +11 more
wiley   +1 more source

Phase 3b Extension Study MT‐1186‐A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral Sclerosis

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims An On/Off dosing regimen of intravenous (IV) edaravone and edaravone oral suspension is currently approved in the US for treatment of amyotrophic lateral sclerosis (ALS). Placebo‐controlled clinical trials showed that IV edaravone slows physical functional decline.
Angela Genge   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy